| DRIOX | TIDDX | DRIOX / TIDDX | |
| Total Expense Ratio | 1.14 | 1.08 | 106% |
| Annual Report Gross Expense Ratio | 1.14 | 1.08 | 106% |
| Fund Existence | 19 years | 11 years | - |
| Gain YTD | 9.965 | 14.227 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 500000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 305M | 6.98B | 4% |
| Annual Yield % from dividends | 1.01 | 1.56 | 65% |
| Returns for 1 year | 13.35 | 15.93 | 84% |
| Returns for 3 years | 55.68 | 52.83 | 105% |
| Returns for 5 years | -9.01 | -10.15 | 89% |
| Returns for 10 years | 26.64 | 65.65 | 41% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYCEX | 105.50 | 1.05 | +1.01% |
| Rydex Europe 1.25x Strategy C | |||
| LVAVX | 17.34 | 0.12 | +0.70% |
| LSV Conservative Value Equity Investor | |||
| WHGOX | 13.52 | 0.03 | +0.22% |
| Westwood Income Opportunity Ultra | |||
| FSCOX | 23.33 | N/A | N/A |
| Fidelity International Small Cap Opp | |||
| JFNSX | 87.14 | N/A | N/A |
| Janus Henderson Global Life Sciences S | |||